Charles Schwab’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $347K | Sell |
299,097
-187,402
| -39% | -$217K | ﹤0.01% | 3273 |
|
|
2025
Q1 | $774K | Sell |
486,499
-10,863
| -2% | -$17.3K | ﹤0.01% | 2936 |
|
|
2024
Q4 | $1.51M | Buy |
497,362
+91,152
| +22% | +$276K | ﹤0.01% | 2766 |
|
|
2024
Q3 | $1.49M | Sell |
406,210
-62,203
| -13% | -$229K | ﹤0.01% | 2793 |
|
|
2024
Q2 | $1.92M | Buy |
468,413
+12,476
| +3% | +$51K | ﹤0.01% | 2717 |
|
|
2024
Q1 | $7.19M | Buy |
455,937
+10,114
| +2% | +$159K | ﹤0.01% | 2152 |
|
|
2023
Q4 | $6.75M | Buy |
445,823
+3,759
| +0.9% | +$56.9K | ﹤0.01% | 2184 |
|
|
2023
Q3 | $8.87M | Buy |
442,064
+36,219
| +9% | +$727K | ﹤0.01% | 1977 |
|
|
2023
Q2 | $11.4M | Buy |
405,845
+72,277
| +22% | +$2.04M | ﹤0.01% | 1850 |
|
|
2023
Q1 | $5.74M | Sell |
333,568
-2,189
| -0.7% | -$37.7K | ﹤0.01% | 2137 |
|
|
2022
Q4 | $6.76M | Buy |
335,757
+12,254
| +4% | +$247K | ﹤0.01% | 2049 |
|
|
2022
Q3 | $7.01M | Buy |
323,503
+2,960
| +0.9% | +$64.1K | ﹤0.01% | 2037 |
|
|
2022
Q2 | $9.01M | Buy |
320,543
+52,706
| +20% | +$1.48M | ﹤0.01% | 1892 |
|
|
2022
Q1 | $12.4M | Buy |
267,837
+6,831
| +3% | +$315K | ﹤0.01% | 1830 |
|
|
2021
Q4 | $21.9M | Buy |
261,006
+8,456
| +3% | +$711K | 0.01% | 1506 |
|
|
2021
Q3 | $16.8M | Buy |
252,550
+98,286
| +64% | +$6.55M | 0.01% | 1708 |
|
|
2021
Q2 | $8.21M | Buy |
154,264
+25,419
| +20% | +$1.35M | ﹤0.01% | 2100 |
|
|
2021
Q1 | $5.59M | Buy |
128,845
+4,357
| +3% | +$189K | ﹤0.01% | 2241 |
|
|
2020
Q4 | $6.47M | Buy |
124,488
+37,817
| +44% | +$1.96M | ﹤0.01% | 2088 |
|
|
2020
Q3 | $2.83M | Buy |
86,671
+20,866
| +32% | +$682K | ﹤0.01% | 2363 |
|
|
2020
Q2 | $3.16M | Buy |
+65,805
| New | +$3.16M | ﹤0.01% | 2252 |
|